Yale Institute for Global Health

9 results

Rate Search Results

News
The Hepatic Arterial Infusion Program at Smilow Cancer Hospital
The Hepatic Arterial Infusion (HAI) Program at Smilow Cancer Hospital provides patients with a specialized and targeted approach to delivering chemotherapy.
14 Jan 2025
News
Chemotherapy Before Surgery Benefits Some Patients With Pancreatic Cancer
“When the study launched, even with operable pancreatic cancers, 90% of patients were still relapsing and dying from their cancer eventually,” said Dr. Michael Cecchini, the first author of the study and the co-director of the colorectal program at the Center for Gastrointestinal Cancers at Smilow Cancer Hospital and YCC. “We sought to move chemotherapy up in their treatment regimen and give it before surgery to see if we could improve the outcome for our patients.”
20 Jun 2024
News
Pancreatic Cancer Risk Lower if Cysts Remain Stable for Five Years
Low-risk branch duct intraductal papillary mucinous neoplasms (IPMN) are the most common precancerous form of mucinous pancreatic cysts and once identified require regular surveillance imaging. But consensus is still forming around how long that watchful period should last. In a new study, Yale Cancer Center researchers question the health benefit of extended surveillance for patients whose cyst has not changed size for at least five years and has no worrisome features.
30 Jun 2023
News
Yale Cancer Center’s Luisa Escobar-Hoyos Awarded NIH High-Risk, High-Reward Grant
Luisa Escobar-Hoyos, MSc, PhD, Assistant Professor of Therapeutic Radiology and Molecular Biophysics and Biochemistry at Yale, was awarded a New Innovator Award from the National Institutes of Health (NIH) through its High-Risk, High-Reward Research Program.
4 Oct 2022
News
Discoveries & Impact (June 2022)
Discoveries & Impact highlights select scientific discoveries per section across the Department of Internal Medicine...
16 Jun 2022
News
Pancreatic Cancer: Team Science Propels New Ideas
Team science propels research in pancreatic cancer, one of the most dangerous gastrointestinal cancers. Collaboration is key for Yale scientists.
16 May 2022
News
Dr. John Kunstman Shares his Perspective in Honor of Pancreatic and Carcinoid Cancers Awareness Months
In recognition of Pancreatic and Carcinoid Cancers Awareness Months and Neuroendocrine Tumors Awareness Day in November, Dr. John Kunstman shares his motivation for treating patients and researching new therapies for these diseases.
29 Nov 2021
News
Smilow Cancer Hospital Surgical Oncology
Smilow Cancer Hospital surgeons provide advanced care and superb clinical outcomes for patients with liver, pancreas, biliary, upper gastrointestinal, and peritoneal surface cancers, in addition to melanoma and sarcoma.
14 Apr 2021
News
Dr. John Kunstman Joins Gastrointestinal Cancers Program
John Kunstman, MD, MHS is an Assistant Professor of Surgery (Oncology) and cares for patients with cancers of the pancreas, liver, bile ducts, stomach, and small intestines at Smilow Cancer Hospital.
12 Nov 2018